Synthetic “mini” receptors block atherosclerosis
New synthetic peptides could attenuate atherosclerosis
Research over the last 20 years has shown that atherosclerosis is a chronic inflammatory condition of the arterial blood vessel wall. Soluble mediators such as cytokines and chemokines are pivotal players in this disease, promoting vascular inflammation. However, the development of anti-inflammatory therapeutics directed against such mediators that could prevent atherosclerosis has proven difficult, despite promising clinical studies in the recent past.
Previous anti-inflammatory therapeutic strategies to prevent atherosclerosis, heart attacks, strokes, rheumatoid arthritis and other inflammatory diseases have mainly been based on antibodies and small molecule drugs. The Munich-based research team has now designed and chemically synthesized short chains of amino acids – i.e. peptides – that function like a minimized soluble chemokine receptor. In animal models, these peptides can block atherosclerosis.
Researchers design a new class of peptides against atherosclerosis
Chemokines orchestrate the migration of immune cells in our bodies. They are key players in inflammatory diseases, including atherosclerosis; and this is why they are of great interest to biomedical researchers.
The peptides designed and synthesized by the Munich researchers mimic certain chemokine receptors and are able to specifically inhibit chemokine mechanisms that promote atherosclerosis, whereas chemokine mechanisms that control important physiological processes in the body are not affected – one could say they are “spared”.
Previous studies have shown the effectiveness of therapeutics related to cytokines and chemokines. However, these drugs, not only interfered with the effect of these mediators on atherosclerosis, but also suppressed their beneficial effects, for example those related to the host defense against infections.
”The mini-CXCR4 mimics we have developed are able to selectively differentiate between two different chemokines that target the same receptor – in this case between the atypical chemokine MIF and the classical chemokine CXCL12. This enables them to specifically block pathways underlying atherosclerosis,” explained Aphrodite Kapurniotu, Professor for Peptide Biochemistry at TUM.
Peptide therapeutics are suitable and inexpensive
”Peptide-based therapeutics are often considered less stable, as peptides may get rapidly degraded in the body by enzymes called proteases. However, we can apply various state-of-the-art approaches of peptide chemistry to improve the stability of peptides, for example by introducing unnatural amino acids into the peptide sequence,” Prof. Kapurniotu added.
”So far, our approach was validated only in an animal model of atherosclerosis, but future clinical applications seem possible, in particular also due to the fact that peptide-based therapeutics are substantially less expensive than antibodies,“ said Prof. Jürgen Bernhagen from the Institute for Stroke and Dementia Research (ISD) at the LMU University Hospital.
Therapeutic potential for inflammation diseases
The Munich researchers view these results as a „proof-of-principle“ of their approach. In fact, their findings show that concepts based on mini-chemokine-receptor mimics are feasible and suggest that this kind of concept could potentially be applied to other chemokines as well.
Thus, the new molecular concept could bear therapeutic potential for atherosclerosis and other inflammatory diseases.
Other news from the department science
Revolutionary cell therapy: rebooting the immune system stops autoimmune diseases
Single infusion of CAR-T cells replaces immunosuppressive drugs
Cracking the Code of Neurodegeneration: New Model Identifies Potential Therapeutic Target
Novel neural cell culture model developed
IQ does not remain the same throughout life
A meta-study shows that an intelligence quotient measured once is not necessarily meaningful later on
New mechanism for regulating cell division in the bacterial pathogen Klebsiella uncovered
Small ribonucleic acid with a big impact
More brain than trait: Decoding the neural pathways of curiosity
Discovery sheds new light on the biological basis of human curiosity and could have far-reaching implications for the understanding and treatment of diseases
What Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
Largest Study on Genetic Risk for Diabetes Now Published
Study Proposes Framework to Standardize Biomarkers of Aging and Accelerate Clinical Use
Improving the life expectancy and health of the population
Researchers succeeded in biomanufacturing using chemically synthesized sugar for the first time in the world
Biomanufacturing using chemically synthesized sugars enables sustainable supply of sugar without competing with food
What can bulls tell us about men?
Towards a better understanding: Which genes and mechanisms control male fertility?
µkiss-and-tell: A new method for precision delivery of nanoparticles and small molecules to individual cells
"Like a paintbrush", easy and cost-effective to use
How COVID-19 affects the brain
Neurological symptoms apparently not a result of SARS-CoV-2 infection of the brain
Microscopy: Overcoming the traditional resolution limit for the fast co-tracking of molecules
Researchers have developed an innovative method to simultaneously track rapid dynamic processes of multiple molecules at the molecular scale
Shredding to plan – protein recycling for immune defense
“If we know how the proteasome generates immunopeptides, we can predict peptide splicing. In future, these predictions could, in turn, help develop novel vaccines against cancer or infectious diseases”
New nanosensors make diagnostic procedures more sensitive
The nanosensors can be used to track reactions with invisible light, saving materials and time
Most read news
mRNA therapeutic successfully combats ovarian cancer
The mRNA therapeutic successfully combated cancerous cells and tumors in vitro as well as metastases in mice
The secret of whales: How giant whales defy cancer
Study of gigantism in whales provides clues to genomic mechanism involved in tumor suppression
A virus that kills sleepers
Researchers have found a virus that kills dormant bacteria: This rare discovery could help to combat germs that can’t be treated with antibiotics alone
Microbe of the Year 2023: Bacillus subtilis – for health and technology
Already, Bacillus subtilis is indispensable in many industries, and many more innovations are expected
Making Ends Meet: Researchers Find That a Protein Superglue is Crucial for DNA Damage Repair
New Understanding for Cancer Treatments
A standard blood test can predict a heart attack
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months
Learning from Nature: How a fungus makes a hard job easier
Researchers analyze a fungal biosynthetic pathway and discover a capable enzyme
Innovative microscopy technique reveals secrets of lipid synthesis inside cells
Two-color infrared photothermal microscopy (2C-IPM) opens new avenues for long-term study of lipid metabolism in living cells
New agent blocks stress response
In the future, this could enable stress-related conditions such as chronic depression to be treated much more specifically and with fewer side effects
Artificial cartilage with the help of 3D printing
New approach to producing artificial tissue works with cells in microstructures from the 3D printer
Destroying Tumor Cells with Calcium
Activating calcium channels leads to a deadly influx of calcium ions into tumor cells
More news from our other portals
Battery start-up is developing safe, long-lasting thin-film solid-state batteries that can be charged and discharged in one minute
BTRY raises CHF 900,000 in pre-seed funding for the development of an innovative solid-state battery
Mystery of Novel Clove-Like Off-Flavor in Orange Juice Solved
Tracking down off-flavours using techniques such as gas chromatography-olfactometry and aroma extract dilution analysis
World first: The first CO2-negative biofuel comes from Germany
Start-up Carbon Farming Germany revolutionizes fuel production with BeyondZero
Planned EU legislation on packaging threatens popular seasonal confectionery
Federal Association of the German Confectionery Industry fears the end of chocolate Easter bunnies & Co.
Chemists are on the hunt for the other 99 percent
New mass spectrometry combo offers promise for tapping nature’s unknown chemical universe
Green steel from toxic red mud
An economical process with green hydrogen can be used to extract CO2-free iron from the red mud generated in aluminium production
BASF and Envision Energy enter a collaboration to drive sustainable energy solutions
Collaboration to accelerate conversion of green hydrogen and CO2 to e-methanol
Eckes-Granini further expands important out-of-home business segment
Market share gains and double-digit sales growth in 2023
GPT-3 for chemical research
Researchers develop fast and user-friendly language model for chemical tasks
Microgreens made to order
Italian scientists have tailored iodine and potassium content of radishes, peas, rocket and chard
Revolutionizing batteries: Coffee grounds power high-performance sodium-ion anodes
Using coffee waste as a precursor material for hard carbon synthesis
Greetings from the island of enhanced stability: The quest for the limit of the periodic table
A fresh view on new superheavy elements
Detect 'forever chemicals' in under 3 minutes
New lab-based method to detect traces of PFAS from food packaging material, water and soil samples